Can leptin, the anti-obesity hormone, protect brain cells?

Award Type
PhD Studentship
Status / Stage
Active
Funder(s)
Alzheimer's Society
Funding Amount
£85,000.00
Funder/Grant study page
Alzheimer's Society
Contracted Centre
University of Dundee
Principal Investigator
Dr Jenni Harvey
PI Contact
j.z.harvey@dundee.ac.uk
WHO Catergories
Development of novel therapies
Risk reduction intervention
Understanding Underlying Disease
Disease Type
Alzheimer's Disease (AD)

CPEC Review Info
Reference ID49
ResearcherReside Team
Published12/06/2023

Data

Status / StageActive
Funder/Grant study pageAlzheimer's Society
Contracted CentreUniversity of Dundee
Funding Amount£85,000.00

Abstract

Researchers believe the build up of proteins amyloid and tau damage the brain cells of people with Alzheimer’s disease. Dr Harvey aims to understand more about whether the anti-obesity hormone, leptin could help to protect against this damage. The research team will be using a number of cell and mouse models of Alzheimer’s disease that replicate the build-up of tau proteins seen in people with the condition. They aim to understand whether leptin protects brain cells from damaged caused by the build-up of tau that interrupts communication between the cells.We know more about dementia today than ever before. However we still have no treatment that can slow down or stop the progression of the condition.This study will help us to understand more about the role of tau in Alzheimer’s disease and tell us more about the potential of leptin as a new treatment.

Aims

To understand whether leptin protects brain cells from damaged caused by the build-up of tau that interrupts communication between the cells.We know more about dementia today than ever before. However we still have no treatment that can slow down or stop the progression of the condition.This study will help us to understand more about the role of tau in Alzheimer’s disease and tell us more about the potential of leptin as a new treatment.